No stock is completely hidden away, of course. To be sure, there are less-trumpeted stocks that you shouldn't buy. Cresco Labs (OTC: CRLBF) doesn't receive as much attention as it deserves, in my opinion.
One Motley Fool contributor is looking forward to the quarterly updates from these healthcare stocks.
DermTech (NASDAQ: DMTK), a company that is trying to redefine testing for skin cancer, has been a sleeper stock for the better half of 2021. The company has created a patch that makes testing for skin cancer easier and more accurate, yet the stock has fallen 60% from its February highs. Here are three things smart investors know before investing in this innovative company.